Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes - Forlenza, G P; Pinhas-Hamiel, O; Liljenquist, D R (Diabetes Technology Therapeutics, 2019)
et al.